Action Points
- This study was published as an abstract and presented at a conference. These data and conclusions should be considered to be preliminary until published in a peer-reviewed journal.
- Use of guideline-recommended cancer therapy increased by more than 50% when oncologists included a tumor's gene expression profile in the decision-making process.
......"The changes that oncologists made in response to the test results weren't limited to the choice of chemotherapy," John Hornberger, MD, of Stanford University, said at the Joint Conference on the Molecular Origins of Lung Cancer.
"Some patients had surgery that initially wasn't planned and, in at least one case, the treating oncologist referred a patient to a different oncologist because the test showed the tissue of origin was different from what was indicated by pathology. Referrals to hospice also increased."..........
